Skip to main content
Top
Published in: Quality of Life Research 4/2019

Open Access 01-04-2019

Health-related quality of life predicted subsequent health care resource utilization in patients with active cancer

Authors: Regina Rendas-Baum, Denise D’Alessio, Jakob Bue Bjorner

Published in: Quality of Life Research | Issue 4/2019

Login to get access

Abstract

Purpose

The objective of this study was to estimate the association between SF-12v2® Health Survey (SF-12v2) scores and subsequent health care resource utilization (HCRU) among patients with cancer.

Methods

We analyzed 18+ year participants in the Medical Expenditure Panel Survey, diagnosed with active cancer or malignancy (n = 647). HCRU was measured by total medical expenditures (MEs) and number of medical events (EVs) in the 6 months following the SF-12v2 assessment. The effect of SF-12v2 scores (physical (PCS) and mental (MCS) component summary scores and the SF-6D health-utility score) on HCRU was estimated using generalized linear models. Estimates were obtained for the entire sample and for the four cancer groups present in the sample: breast, prostate, skin, and lung.

Results

For PCS and MCS, a one-point better score was associated with 2% lower MEs (P < 0.001) and 2.5% lower MEs (P = 0.015), respectively. A 0.05-point better SF-6D score was associated with 7% lower MEs (P = 0.003). PCS and SF-6D were more strongly associated with MEs for prostate cancer patients (P = 0.009 and P = 0.003) and PCS was more strongly associated with MEs for skin cancer patients (P = 0.019), compared to other cancer groups. A 1-point better PCS predicted 1% lower EVs, while a 0.05 better SF-6D score predicted 4% lower EVs.

Conclusions

The significant associations between SF-12v2 scores from oncology patients and subsequent HCRU can guide interpretations of SF-12v2 scores in evaluation of therapies and in health policy decisions.
Footnotes
1
Based on prior recommendations [32], given our sample’s skewness for total expenditures (Fisher’s skewness measure G1 = 4.42), a sample size ≥ 489 is suitable for estimation of the mean.
 
Literature
1.
go back to reference Agency for Healthcare Research and Quality. (2017). Total expenses and percent distribution for selected conditions by type of service: United States, 2014. Medical expenditure panel survey household component data. Generated interactively (November 22, 2017). Agency for Healthcare Research and Quality. (2017). Total expenses and percent distribution for selected conditions by type of service: United States, 2014. Medical expenditure panel survey household component data. Generated interactively (November 22, 2017).
3.
go back to reference Zagadailov, E., Fine, M., & Shields, A. (2013). Patient-reported outcomes are changing the landscape in oncology care: Challenges and opportunities for payers. American Health & Drug Benefits, 6(5), 264–274. Zagadailov, E., Fine, M., & Shields, A. (2013). Patient-reported outcomes are changing the landscape in oncology care: Challenges and opportunities for payers. American Health & Drug Benefits, 6(5), 264–274.
17.
go back to reference Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.CrossRefPubMed Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.CrossRefPubMed
19.
go back to reference Maruish, M. E. (Ed.). (2012). User’s manual for the SF-12v2 health survey (3rd ed.). Lincoln: QualityMetric Inc. Maruish, M. E. (Ed.). (2012). User’s manual for the SF-12v2 health survey (3rd ed.). Lincoln: QualityMetric Inc.
20.
go back to reference Bellardita, L., Damiano, R., Porpiglia, F., Scattoni, V., Amodeo, A., Bortolus, R., et al. (2016). Adaptation and validation of an Italian version of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI). European Review for Medical and Pharmacological Sciences, 20, 2773–2778.PubMed Bellardita, L., Damiano, R., Porpiglia, F., Scattoni, V., Amodeo, A., Bortolus, R., et al. (2016). Adaptation and validation of an Italian version of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI). European Review for Medical and Pharmacological Sciences, 20, 2773–2778.PubMed
23.
go back to reference de Oliveira A. L., Mendes, L. L., Netto, M. P., & Leite, I. C. G. (2017). Cross-cultural adaptation and validation of the stoma quality of life questionnaire for patients with a colostomy or ileostomy in Brazil: A cross-sectional Study. Ostomy Wound Manage, 63, 34–41. de Oliveira A. L., Mendes, L. L., Netto, M. P., & Leite, I. C. G. (2017). Cross-cultural adaptation and validation of the stoma quality of life questionnaire for patients with a colostomy or ileostomy in Brazil: A cross-sectional Study. Ostomy Wound Manage, 63, 34–41.
25.
26.
go back to reference Manning, W. G., & Mullahy, J. (2001). Estimating log models: To transform or not to transform? Journal of Health Economics, 20, 461–494.CrossRefPubMed Manning, W. G., & Mullahy, J. (2001). Estimating log models: To transform or not to transform? Journal of Health Economics, 20, 461–494.CrossRefPubMed
27.
go back to reference Manning, W. G., Basu, A., & Mullahy, J. (2003). Generalized modeling approaches to risk adjustment of skewed outcomes data. NBER Technical Working Paper, Cambridge, MA. Manning, W. G., Basu, A., & Mullahy, J. (2003). Generalized modeling approaches to risk adjustment of skewed outcomes data. NBER Technical Working Paper, Cambridge, MA.
29.
go back to reference Wang, S., Shah, N., Philip, J., Caraccio, T., Feuerman, M., & Malone, B. (2012). Role of alvimopan (entereg) in gastrointestinal recovery and hospital length of stay after bowel resection. Pharmacy and Therapeutics, 37(9), 518–525.PubMedPubMedCentral Wang, S., Shah, N., Philip, J., Caraccio, T., Feuerman, M., & Malone, B. (2012). Role of alvimopan (entereg) in gastrointestinal recovery and hospital length of stay after bowel resection. Pharmacy and Therapeutics, 37(9), 518–525.PubMedPubMedCentral
30.
go back to reference Fragoso, C. A. V., Murphy, T. E., Agogo, G. O., Allore, H. G., & McAvay, G. J. (2017). Asthma-COPD overlap syndrome in the US: A prospective population-based analysis of patient-reported outcomes and health care utilization. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/COPD.S121223.CrossRef Fragoso, C. A. V., Murphy, T. E., Agogo, G. O., Allore, H. G., & McAvay, G. J. (2017). Asthma-COPD overlap syndrome in the US: A prospective population-based analysis of patient-reported outcomes and health care utilization. International Journal of Chronic Obstructive Pulmonary Disease. https://​doi.​org/​10.​2147/​COPD.​S121223.CrossRef
32.
go back to reference Yu, W. W., & Machlin, S. R. (2005). An examination of skewed health expenditure data from the Medical Expenditure Panel Survey (MEPS). Journal of Economic and Social Measurement, 30(2), 127–134.CrossRef Yu, W. W., & Machlin, S. R. (2005). An examination of skewed health expenditure data from the Medical Expenditure Panel Survey (MEPS). Journal of Economic and Social Measurement, 30(2), 127–134.CrossRef
Metadata
Title
Health-related quality of life predicted subsequent health care resource utilization in patients with active cancer
Authors
Regina Rendas-Baum
Denise D’Alessio
Jakob Bue Bjorner
Publication date
01-04-2019
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 4/2019
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-2085-z

Other articles of this Issue 4/2019

Quality of Life Research 4/2019 Go to the issue